Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 9464127 Fusion molecules and IL-15 variants

Patent 9464127 was granted and assigned to Altor BioScience on October, 2016 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
0
Current Assignee
Altor BioScience
Altor BioScience
0
Date Filed
July 19, 2013
0
Date of Patent
October 11, 2016
0
Patent Applicant
Altor BioScience
Altor BioScience
0
Patent Application Number
13946438
0
Patent Citations Received
‌
US Patent 11673932 Fusion molecules and IL-15 variants
0
‌
US Patent 11679144 IL-15-based molecules and methods of use thereof
0
‌
US Patent 11965007 IL-15-based fusions to IL-7 and IL-21
0
‌
US Patent 11992516 Compositions comprising IL-15-based molecules and immune checkpoint inhibitor antibodies
0
‌
US Patent 11890323 Method of treating cancer with composition comprising IL-15-based molecules and BCG
0
‌
US Patent 11925676 Method for treating neoplasia with an anti-CD38 antibody and an IL-15:IL-15R complex
0
‌
US Patent 11932675 PD-1 targeted IL-15/IL-15Rα Fc fusion proteins with improved properties
0
‌
US Patent 11872272 IL-15-based fusions to IL-12 and IL-18
0
‌
US Patent 11975059 IL-15-based fusions to IL-12 and IL-18
0
Patent Inventor Names
Hing C. Wong
0
Kai-ping Han
0
Peter Rhode
0
Xiaoyun Zhu
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
9464127
0
Patent Primary Examiner
‌
Bridget E Bunner
0

Find more entities like US Patent 9464127 Fusion molecules and IL-15 variants

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo